AMAG Pharmaceuticals Just Filed Its Quarterly Report: The components of b...

The components of basic and diluted net loss per share were as follows (in thousands, except per share data):




Three Months Ended March 31,








Net loss








Weighted average common shares outstanding






Net loss per share:






Basic and diluted









The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever AMAG Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

SVP of AMAG Pharmaceuticals just disposed of 859 shares - Dec. 18, 2014
SVP of AMAG Pharmaceuticals just disposed of 1,789 shares - Dec. 18, 2014
EVP of AMAG Pharmaceuticals just disposed of 7,046 shares - Dec. 18, 2014
AMAG Pharmaceuticals's President and CEO just disposed of 9,890 shares - Dec. 18, 2014
AMAG: Departures Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers - Dec. 11, 2014

   Auto Refresh